{"id":18184,"date":"2023-05-01T10:30:00","date_gmt":"2023-05-01T10:30:00","guid":{"rendered":"https:\/\/www.prnasia.com\/story\/archive\/4084940_AE84940_0"},"modified":"2023-05-01T10:30:00","modified_gmt":"2023-05-01T10:30:00","slug":"concept-medical-received-ide-approval-to-investigate-safety-and-efficacy-of-its-magictouch-sirolimus-coated-balloon-catheter-for-the-treatment-of-small-coronary-artery-disease","status":"publish","type":"post","link":"https:\/\/transmediavictoria.net.au\/?p=18184","title":{"rendered":"Concept Medical received IDE approval to investigate safety and efficacy of its MagicTouch Sirolimus Coated Balloon Catheter for the treatment of small coronary artery disease"},"content":{"rendered":"<div id=\"dvContent\" readability=\"93.178287981859\">\n<table name=\"logo_release\" border=\"0\" cellspacing=\"10\" cellpadding=\"5\" align=\"right\">\n<tbody>\n<tr>\n<td><img decoding=\"async\" src=\"https:\/\/mma.prnasia.com\/media2\/1926812\/Concept_Medical_Logo.jpg?p=medium600\" border=\"0\" alt title=\"logo\" hspace=\"0\" vspace=\"0\" width=\"118\"><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><span class=\"xn-location\">TAMPA, Fla.<\/span>, <span class=\"xn-chron\">May 1, 2023<\/span> \/PRNewswire\/ &#8212;&nbsp;The US FDA has granted an Investigational Device Exemption (IDE) approval for Concept Medical Inc&#8217;s novel <a href=\"https:\/\/www.conceptmedical.com\/product\/magic-touch\/\" target=\"_blank\" rel=\"nofollow noopener\">MagicTouch<\/a> Sirolimus Coated Balloon (SCB) for the treatment of Small Vessels (SV) in coronary arteries.<\/p>\n<div id=\"prni_dvprnejpg63e3left\" dir=\"ltr\"> <a href=\"https:\/\/mma.prnasia.com\/media2\/2066748\/Concept_Medical.jpg?p=medium600\" target=\"_blank\" rel=\"noopener\"><img decoding=\"async\" id=\"prnejpg63e3left\" title=\"Concept Medical has received its third US FDA IDE approval for the MagicTouch - Sirolimus Coated Balloon in Small Vessel Indication.\" src=\"https:\/\/mma.prnasia.com\/media2\/2066748\/Concept_Medical.jpg?p=medium600\" alt=\"Concept Medical has received its third US FDA IDE approval for the MagicTouch - Sirolimus Coated Balloon in Small Vessel Indication.\" align=\"middle\" data-name=\"url$https%3A%2F%2Fmma.prnewswire.com%2Fmedia%2F2066748%2FConcept_Medical.jpg;width$400;height$225\"><\/a> <br \/><span>Concept Medical has received its third US FDA IDE approval for the MagicTouch &#8211; Sirolimus Coated Balloon in Small Vessel Indication.<\/span> <\/div>\n<p>US FDA, on the 25<sup>th<\/sup> of <span class=\"xn-chron\">April 2023<\/span>, granted the third IDE approval for Concept Medical&#8217;s Sirolimus Coated Balloon \u2013 MagicTouch SCB. Along with this latest IDE approval for the treatment of Small Vessel indication, Concept Medical received two other IDE approvals for the MagicTouch SCB family of products for the treatment of coronary <a href=\"https:\/\/www.conceptmedical.com\/press-release\/magictouch-scb-receives-ide-approval-for-in-stent-restenosis-indication\/\" target=\"_blank\" rel=\"nofollow noopener\">In-Stent Restenosis<\/a> (ISR) indication and <a href=\"https:\/\/www.conceptmedical.com\/press-release\/concept-medical-granted-investigational-device-exemption-ide-approval-for-their-magic-touch-sirolimus-coated-balloon-for-the-treatment-of-below-the-knee-btk-arterial-disease\/\" target=\"_blank\" rel=\"nofollow noopener\">Below-the-Knee indication<\/a> (PTA).<\/p>\n<p>Small vessel disease is common among patients undergoing PCI and has been documented in up to 30% of cases and Myocardial revascularization of small vessels remains challenging owing to increased rates of technical failure following coronary artery bypass graft surgery and an increased risk of restenosis with PCI resulting with repeated interventions. Small Vessel Disease also remains an independent predictor of major adverse cardiac events (MACE).<\/p>\n<p>The current IDE approval will allow <a href=\"https:\/\/www.conceptmedical.com\/\" target=\"_blank\" rel=\"nofollow noopener\">Concept Medical<\/a> to initiate pivotal clinical study to support safety and effectiveness of the MagicTouch SCB in small vessel coronary disease. The data generated from this IDE clinical study will support a future pre-market approval (PMA) application in the <span class=\"xn-location\">USA<\/span>.<\/p>\n<p><a href=\"https:\/\/www.conceptmedical.com\/product\/magic-touch\/\" target=\"_blank\" rel=\"nofollow noopener\">MagicTouch SCB<\/a> is the world&#8217;s first Sirolimus&nbsp;coated Balloon with extensive commercial usage in <span class=\"xn-location\">Europe<\/span>, major markets of <span class=\"xn-location\">Asia<\/span> and the Mid-Eastern markets. More than 100 thousand patients have been treated with MagicTouch SCB in these markets.<\/p>\n<p>Currently, there are no FDA approved Drug Coated Balloons for the treatment of CAD in the <span class=\"xn-location\">USA<\/span>. The physicians&#8217; choices are restricted to Drug Eluting Stents and uncoated Balloons. MagicTouch SCB has already been widely studied globally in multiple clinical trials, most notably the EASTBOURNE Registry (2123 patients), NANOLUTE, and ongoing trials like the TRANSFORM 1, TRANSFORM 2, GINGER, TITAN, and Hybrid Bifurcation DEB. Sirolimus has already proven to be safer in coronary artery disease treatment.<\/p>\n<p>Dr. <span class=\"xn-person\">Martin Leon<\/span>, MD (Founder and Chairman Emeritus, Cardiovascular Research Foundation), who will lead the coming IDE Trials, stresses on the importance of this achievement, &#8220;The FDA-approval to initiate the MAGICAL-SV Clinical trial using the MagicTouch sirolimus-covered&nbsp;balloon with novel coating technology represents a landmark event in our decades-long quest to find an optimal therapy to manage patients with small vessel coronary obstructive disease. Our US clinical investigators are thrilled and anxious to begin enrolment in close collaboration with the Cardiovascular Research Foundation and Concept Medical.&#8221;<\/p>\n<p><b>About MagicTouch SCB:<\/b><\/p>\n<p><a href=\"https:\/\/www.conceptmedical.com\/product\/magic-touch\/\" target=\"_blank\" rel=\"nofollow noopener\">MagicTouch SCB<\/a> is a CE marked and commercially marketed Sirolimus coated balloon developed by Concept Medical, using proprietary <a href=\"https:\/\/www.conceptmedical.com\/technology\/nanolute\/\" target=\"_blank\" rel=\"nofollow noopener\">Nanolut\u00e9 Technology<\/a>. MagicTouch SCB has been used in &gt;50,000 patients in major global markets.<\/p>\n<p><b>About <a href=\"https:\/\/www.conceptmedical.com\/\" target=\"_blank\" rel=\"nofollow noopener\">Concept Medical Inc<\/a> (CMI):<\/b><\/p>\n<p><a href=\"https:\/\/www.conceptmedical.com\/\" target=\"_blank\" rel=\"nofollow noopener\">CMI<\/a> is headquartered in <span class=\"xn-location\">Tampa, Florida<\/span> and has operational offices in <span class=\"xn-location\">The Netherlands<\/span>, <span class=\"xn-location\">Singapore<\/span> and <span class=\"xn-location\">Brazil<\/span> and manufacturing units in <span class=\"xn-location\">India<\/span>. CMI specializes in developing unique combination products with a patented coating technology that can deliver any drug \/ pharmaceutical agent across the luminal surfaces of blood vessels.<\/p>\n<\/p><\/div>\n<p>Source: Concept Medical Inc.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>TAMPA, Fla., May 1, 2023 \/PRNewswire\/ &#8212;&nbsp;The US FDA has granted an Investigational Device Exemption (IDE) approval for Concept Medical Inc&#8217;s novel MagicTouch Sirolimus Coated Balloon (SCB) for the treatment of Small Vessels (SV) in coronary arteries. Concept Medical has received its third US FDA IDE approval for the MagicTouch &#8211; Sirolimus Coated Balloon in [&hellip;]<\/p>\n","protected":false},"author":8,"featured_media":18185,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[20],"tags":[],"class_list":["post-18184","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-business-news"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.9 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Concept Medical received IDE approval to investigate safety and efficacy of its MagicTouch Sirolimus Coated Balloon Catheter for the treatment of small coronary artery disease - My Blog<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/transmediavictoria.net.au\/?p=18184\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Concept Medical received IDE approval to investigate safety and efficacy of its MagicTouch Sirolimus Coated Balloon Catheter for the treatment of small coronary artery disease - My Blog\" \/>\n<meta property=\"og:description\" content=\"TAMPA, Fla., May 1, 2023 \/PRNewswire\/ &#8212;&nbsp;The US FDA has granted an Investigational Device Exemption (IDE) approval for Concept Medical Inc&#8217;s novel MagicTouch Sirolimus Coated Balloon (SCB) for the treatment of Small Vessels (SV) in coronary arteries. Concept Medical has received its third US FDA IDE approval for the MagicTouch &#8211; Sirolimus Coated Balloon in [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/transmediavictoria.net.au\/?p=18184\" \/>\n<meta property=\"og:site_name\" content=\"My Blog\" \/>\n<meta property=\"article:published_time\" content=\"2023-05-01T10:30:00+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mma.prnasia.com\/media2\/1926812\/Concept_Medical_Logo.jpg?p=medium600\" \/>\n<meta name=\"author\" content=\"admin_tony\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"admin_tony\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=18184#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=18184\"},\"author\":{\"name\":\"admin_tony\",\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/#\\\/schema\\\/person\\\/5b51d407d652c0aa802bea269ea5d7e7\"},\"headline\":\"Concept Medical received IDE approval to investigate safety and efficacy of its MagicTouch Sirolimus Coated Balloon Catheter for the treatment of small coronary artery disease\",\"datePublished\":\"2023-05-01T10:30:00+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=18184\"},\"wordCount\":542,\"image\":{\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=18184#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/transmediavictoria.net.au\\\/wp-content\\\/uploads\\\/2023\\\/05\\\/concept-medical-received-ide-approval-to-investigate-safety-and-efficacy-of-its-magictouch-sirolimus-coated-balloon-catheter-for-the-treatment-of-small-coronary-artery-disease.jpg\",\"articleSection\":[\"Business News\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=18184\",\"url\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=18184\",\"name\":\"Concept Medical received IDE approval to investigate safety and efficacy of its MagicTouch Sirolimus Coated Balloon Catheter for the treatment of small coronary artery disease - My Blog\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=18184#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=18184#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/transmediavictoria.net.au\\\/wp-content\\\/uploads\\\/2023\\\/05\\\/concept-medical-received-ide-approval-to-investigate-safety-and-efficacy-of-its-magictouch-sirolimus-coated-balloon-catheter-for-the-treatment-of-small-coronary-artery-disease.jpg\",\"datePublished\":\"2023-05-01T10:30:00+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/#\\\/schema\\\/person\\\/5b51d407d652c0aa802bea269ea5d7e7\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=18184#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=18184\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=18184#primaryimage\",\"url\":\"https:\\\/\\\/transmediavictoria.net.au\\\/wp-content\\\/uploads\\\/2023\\\/05\\\/concept-medical-received-ide-approval-to-investigate-safety-and-efficacy-of-its-magictouch-sirolimus-coated-balloon-catheter-for-the-treatment-of-small-coronary-artery-disease.jpg\",\"contentUrl\":\"https:\\\/\\\/transmediavictoria.net.au\\\/wp-content\\\/uploads\\\/2023\\\/05\\\/concept-medical-received-ide-approval-to-investigate-safety-and-efficacy-of-its-magictouch-sirolimus-coated-balloon-catheter-for-the-treatment-of-small-coronary-artery-disease.jpg\",\"width\":599,\"height\":337},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=18184#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/transmediavictoria.net.au\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Concept Medical received IDE approval to investigate safety and efficacy of its MagicTouch Sirolimus Coated Balloon Catheter for the treatment of small coronary artery disease\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/#website\",\"url\":\"https:\\\/\\\/transmediavictoria.net.au\\\/\",\"name\":\"My Blog\",\"description\":\"My WordPress Blog\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/#\\\/schema\\\/person\\\/5b51d407d652c0aa802bea269ea5d7e7\",\"name\":\"admin_tony\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/102836fe5f9cd6c64e96e90e7341dbc815b7d12726a85708326dc0db40afd906?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/102836fe5f9cd6c64e96e90e7341dbc815b7d12726a85708326dc0db40afd906?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/102836fe5f9cd6c64e96e90e7341dbc815b7d12726a85708326dc0db40afd906?s=96&d=mm&r=g\",\"caption\":\"admin_tony\"},\"url\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?author=8\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Concept Medical received IDE approval to investigate safety and efficacy of its MagicTouch Sirolimus Coated Balloon Catheter for the treatment of small coronary artery disease - My Blog","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/transmediavictoria.net.au\/?p=18184","og_locale":"en_US","og_type":"article","og_title":"Concept Medical received IDE approval to investigate safety and efficacy of its MagicTouch Sirolimus Coated Balloon Catheter for the treatment of small coronary artery disease - My Blog","og_description":"TAMPA, Fla., May 1, 2023 \/PRNewswire\/ &#8212;&nbsp;The US FDA has granted an Investigational Device Exemption (IDE) approval for Concept Medical Inc&#8217;s novel MagicTouch Sirolimus Coated Balloon (SCB) for the treatment of Small Vessels (SV) in coronary arteries. Concept Medical has received its third US FDA IDE approval for the MagicTouch &#8211; Sirolimus Coated Balloon in [&hellip;]","og_url":"https:\/\/transmediavictoria.net.au\/?p=18184","og_site_name":"My Blog","article_published_time":"2023-05-01T10:30:00+00:00","og_image":[{"url":"https:\/\/mma.prnasia.com\/media2\/1926812\/Concept_Medical_Logo.jpg?p=medium600","type":"","width":"","height":""}],"author":"admin_tony","twitter_card":"summary_large_image","twitter_misc":{"Written by":"admin_tony","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/transmediavictoria.net.au\/?p=18184#article","isPartOf":{"@id":"https:\/\/transmediavictoria.net.au\/?p=18184"},"author":{"name":"admin_tony","@id":"https:\/\/transmediavictoria.net.au\/#\/schema\/person\/5b51d407d652c0aa802bea269ea5d7e7"},"headline":"Concept Medical received IDE approval to investigate safety and efficacy of its MagicTouch Sirolimus Coated Balloon Catheter for the treatment of small coronary artery disease","datePublished":"2023-05-01T10:30:00+00:00","mainEntityOfPage":{"@id":"https:\/\/transmediavictoria.net.au\/?p=18184"},"wordCount":542,"image":{"@id":"https:\/\/transmediavictoria.net.au\/?p=18184#primaryimage"},"thumbnailUrl":"https:\/\/transmediavictoria.net.au\/wp-content\/uploads\/2023\/05\/concept-medical-received-ide-approval-to-investigate-safety-and-efficacy-of-its-magictouch-sirolimus-coated-balloon-catheter-for-the-treatment-of-small-coronary-artery-disease.jpg","articleSection":["Business News"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/transmediavictoria.net.au\/?p=18184","url":"https:\/\/transmediavictoria.net.au\/?p=18184","name":"Concept Medical received IDE approval to investigate safety and efficacy of its MagicTouch Sirolimus Coated Balloon Catheter for the treatment of small coronary artery disease - My Blog","isPartOf":{"@id":"https:\/\/transmediavictoria.net.au\/#website"},"primaryImageOfPage":{"@id":"https:\/\/transmediavictoria.net.au\/?p=18184#primaryimage"},"image":{"@id":"https:\/\/transmediavictoria.net.au\/?p=18184#primaryimage"},"thumbnailUrl":"https:\/\/transmediavictoria.net.au\/wp-content\/uploads\/2023\/05\/concept-medical-received-ide-approval-to-investigate-safety-and-efficacy-of-its-magictouch-sirolimus-coated-balloon-catheter-for-the-treatment-of-small-coronary-artery-disease.jpg","datePublished":"2023-05-01T10:30:00+00:00","author":{"@id":"https:\/\/transmediavictoria.net.au\/#\/schema\/person\/5b51d407d652c0aa802bea269ea5d7e7"},"breadcrumb":{"@id":"https:\/\/transmediavictoria.net.au\/?p=18184#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/transmediavictoria.net.au\/?p=18184"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/transmediavictoria.net.au\/?p=18184#primaryimage","url":"https:\/\/transmediavictoria.net.au\/wp-content\/uploads\/2023\/05\/concept-medical-received-ide-approval-to-investigate-safety-and-efficacy-of-its-magictouch-sirolimus-coated-balloon-catheter-for-the-treatment-of-small-coronary-artery-disease.jpg","contentUrl":"https:\/\/transmediavictoria.net.au\/wp-content\/uploads\/2023\/05\/concept-medical-received-ide-approval-to-investigate-safety-and-efficacy-of-its-magictouch-sirolimus-coated-balloon-catheter-for-the-treatment-of-small-coronary-artery-disease.jpg","width":599,"height":337},{"@type":"BreadcrumbList","@id":"https:\/\/transmediavictoria.net.au\/?p=18184#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/transmediavictoria.net.au\/"},{"@type":"ListItem","position":2,"name":"Concept Medical received IDE approval to investigate safety and efficacy of its MagicTouch Sirolimus Coated Balloon Catheter for the treatment of small coronary artery disease"}]},{"@type":"WebSite","@id":"https:\/\/transmediavictoria.net.au\/#website","url":"https:\/\/transmediavictoria.net.au\/","name":"My Blog","description":"My WordPress Blog","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/transmediavictoria.net.au\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/transmediavictoria.net.au\/#\/schema\/person\/5b51d407d652c0aa802bea269ea5d7e7","name":"admin_tony","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/102836fe5f9cd6c64e96e90e7341dbc815b7d12726a85708326dc0db40afd906?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/102836fe5f9cd6c64e96e90e7341dbc815b7d12726a85708326dc0db40afd906?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/102836fe5f9cd6c64e96e90e7341dbc815b7d12726a85708326dc0db40afd906?s=96&d=mm&r=g","caption":"admin_tony"},"url":"https:\/\/transmediavictoria.net.au\/?author=8"}]}},"_links":{"self":[{"href":"https:\/\/transmediavictoria.net.au\/index.php?rest_route=\/wp\/v2\/posts\/18184","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/transmediavictoria.net.au\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/transmediavictoria.net.au\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/transmediavictoria.net.au\/index.php?rest_route=\/wp\/v2\/users\/8"}],"replies":[{"embeddable":true,"href":"https:\/\/transmediavictoria.net.au\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=18184"}],"version-history":[{"count":0,"href":"https:\/\/transmediavictoria.net.au\/index.php?rest_route=\/wp\/v2\/posts\/18184\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/transmediavictoria.net.au\/index.php?rest_route=\/wp\/v2\/media\/18185"}],"wp:attachment":[{"href":"https:\/\/transmediavictoria.net.au\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=18184"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/transmediavictoria.net.au\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=18184"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/transmediavictoria.net.au\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=18184"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}